angiotensin ii has been researched along with rotenone in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| McMurtry, IF; Rounds, S | 1 |
| Ahmadi, F; Fariss, MW; Grammatopoulos, TN; Jones, SM; Weyhenmeyer, JA; Zawada, WM | 1 |
| Herbert, KE; Mistry, Y; Poolman, T; Williams, B | 1 |
| Ding, G; Huang, S; Jia, Z; Sun, Y; Zhang, A; Zhang, Y | 1 |
| Kim, SJ; Shao, YF; Sudarshan, VK; Wu, YN; Zhang, YH; Zhu, SC | 1 |
6 other study(ies) available for angiotensin ii and rotenone
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Inhibitors of oxidative ATP production cause transient vasoconstriction and block subsequent pressor responses in rat lungs.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Antimycin A; Azides; Blood Pressure; Calcium; Dinitrophenols; Hypoxia; Lung; Male; Perfusion; Potassium Cyanide; Pulmonary Circulation; Rats; Rotenone; Sodium Azide; Solvents; Vasoconstriction; Verapamil | 1981 |
Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell death.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Cell Death; Cells, Cultured; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Amino Acid Antagonists; Insecticides; Losartan; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Oxidative Stress; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Rotenone; Substantia Nigra; Tyrosine 3-Monooxygenase | 2005 |
A role for mitochondrial oxidants in stress-induced premature senescence of human vascular smooth muscle cells.
Topics: Angiotensin II; Cells, Cultured; Cellular Senescence; Humans; Mitochondria; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Oxidative Stress; Receptors, Angiotensin; Rotenone; Superoxides | 2013 |
Inhibition of Mitochondrial Complex-1 Prevents the Downregulation of NKCC2 and ENaCĪ± in Obstructive Kidney Disease.
Topics: Angiotensin II; Animals; Dinoprostone; Electron Transport Complex I; Epithelial Sodium Channels; Gene Expression Regulation; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mitochondria; Natriuretic Peptide, Brain; Nitric Oxide; Nitric Oxide Synthase Type II; Rotenone; Signal Transduction; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Potassium-Exchanging ATPase; Solute Carrier Family 12, Member 1; Solute Carrier Family 12, Member 3; Ureteral Obstruction | 2015 |
Functional interactions between complex I and complex II with nNOS in regulating cardiac mitochondrial activity in sham and hypertensive rat hearts.
Topics: Angiotensin II; Animals; Cells, Cultured; Citrulline; Electron Transport Complex I; Electron Transport Complex II; Enzyme Inhibitors; Hypertension; Male; Malonates; Mitochondria, Heart; Myocytes, Cardiac; Nitric Oxide Synthase Type I; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Rotenone; Thiourea | 2020 |